Covered recipient · General Payments record
CECILIA CASSIDY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,240.12
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,151.87 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $470.23 | 4 |
| Abbott Laboratories | $292.86 | 2 |
| Lilly USA, LLC | $152.31 | 2 |
| Xeris Pharmaceuticals, Inc. | $118.71 | 1 |
| Amgen Inc. | $117.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $142.86 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124857923 | CMS |
| Abbott Laboratories | $150.00 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124857921 | CMS |
| Amgen Inc. | $117.76 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115484854 | CMS |
| AstraZeneca Pharmaceuticals LP | $112.70 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105721174 | CMS |
| AstraZeneca Pharmaceuticals LP | $112.59 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105562646 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.94 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104263059 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105865334 | CMS |
| Lilly USA, LLC | $33.92 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135555994 | CMS |
| Lilly USA, LLC | $118.39 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135588659 | CMS |
| Xeris Pharmaceuticals, Inc. | $118.71 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144622670 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.